Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Kazia Therapeutics Logo
Kazia Therapeutics Growth Score
62
CB Rank
49955
Heat Score
69
Kazia Therapeutics is an oncology focused biotechnology company.
Founded
obfuscation
PublicPost-IPO Equity Hornsby, New South Wales, Australia11-50 www.kaziatherapeutics.com/
Biotechnology
Clinical Trials
Commercial
Innovation Management
Oncology
Pharmaceutical
Overview

Kazia Therapeutics
Total Funding
obfuscation
Growth Score
62
Heat Score
69

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score62
-8 pts
in past quarter
Heat Score 69
8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Kazia Therapeutics

CB Rank
49955
Kazia Therapeutics is an oncology focused biotechnology company.
Founded
obfuscation
PublicPost-IPO Equity Hornsby, New South Wales, Australia11-50 www.kaziatherapeutics.com/
Biotechnology
Clinical Trials
Commercial
Innovation Management
Oncology
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Graham Kelly
    Graham Kelly: Founder ,Executive Director, CEO & Chairman
  • Photo of John Friend
    John Friend: Chief Executive Officer
    Past Role: Kazia Therapeutics, Chief Medical Officer

Details

Legal Name Kazia Therapeutics Limited
Also Known As Novogen
Operating Status Active
Stock Symbol  NASDAQ:KZIA
Company Type For Profit
Founders  Graham Kelly
About the Company
Kazia Therapeutics is an oncology focused biotechnology company, developing innovative anti-cancer drugs. Kazia Therapeutics collaborates with leading scientists, clinicians and investors around the world.
Phone Number +61 2 9472 4100
Contact Email info@novogen.com
Predictions & Insights

Growth Insight

See this Growth Insight
Kazia Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

Paxalisib
A small molecule inhibitor targeting the PI3K/Akt/mTOR pathway, developed for treating various brain cancers including glioblastoma.
EVT801
A small molecule inhibitor of VEGFR3, designed to inhibit tumor blood vessel and lymphatic vessel formation, under development for advanced cancers.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 8
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity
obfuscation
Post-IPO Equity - Kazia Therapeutics Logo
Post-IPO Equity - Kazia Therapeutics
6
obfuscation
ADAR1 Capital Management, Ikarian Capital, Revach Capital Management, Stonepine Capital Management, Velan CapitalPost-IPO Equity

Investors

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 4 Contacts 4

Employee Profiles

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

277
-71.35%
 in past month

Interest Signals

TopicSurge Score
Autodesk (ADSK) Logo
Autodesk (ADSK)
90
Motorola Solutions (MSI) Logo
Motorola Solutions (MSI)
89
Academic Integrity Logo
Academic Integrity
84

Actively Used Products

14Kazia Therapeutics uses 14 technology products and services including HTML5, jQuery, and  Google Analytics, according to G2 Stack.

Active Website Tech Count

34Kazia Therapeutics is actively using 34 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, SSL by Default, and  Viewport Meta.

Total IP

6The intellectual property of Kazia Therapeutics includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Kazia Therapeutics has registered 4 trademarks with the most popular class being 'Chemical substances', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Kazia Therapeutics's headquarters? Kazia Therapeutics is located in Hornsby, New South Wales, Australia.Who invested in Kazia Therapeutics? Kazia Therapeutics has 7 investors including Revach Capital Management and  Stonepine Capital Management.When was the last funding round for Kazia Therapeutics? Kazia Therapeutics closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Kazia Therapeutics's competitors? Alternatives and possible competitors to Kazia Therapeutics may include Iambic, Storm Therapeutics, and  Acrivon Therapeutics.How much funding has Kazia Therapeutics raised to date? Kazia Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|